 |
|
|
| |
Virologic response to an interferon-free regimen of BI 201335 and BI 207127, with and without ribavirin, in treatment-naïve patients with chronic genotype-1 HCV infection: Week 12 interim results of the SOUND-C2 study
|
| |
| |
Reported by Jules Levin AASLD Nov 5-9 2011 SF
Stefan Zeuzem,1 Vincent Soriano,2 Tarik Asselah,3 Jean-Pierre Bronowicki,4 Emanoil Ceausu,5 Ansgar W. Lohse,6 Adrian Streinu-Cercel,7 Liliana Preotescu,7 Joseph Moussalli,8 Beat Mullhaupt,9 Marcus Schuchmann,10 Marc Bourliere,11 Filipe Calinas,12 Maria Buti,13 Stuart K. Roberts,14 Edward J. Gane,15 Jerry O. Stern,16 Gerhard Nehmiz,17 Helge Bonaventura,17 Wulf O. Boecher,17 Federico J. Mensa16
1Klinikum der J.W. Goethe-Universitat, Frankfurt, Germany; 2Hospital Carlos III, Madrid, Spain; 3Hopital Beaujon, Clichy Cedex, France; 4Hopital de Brabois, Vandoeuvre Cedex, France; 5"Dr Victor Babes" Hospital of Infectious Diseases, Bucharest, Romania; 6Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany; 7"Prof. Dr. Matei Bals" Institute of Infectious Diseases, Bucharest, Romania; 8Hopital Pitie Salpetriere, Paris, France; 9Universitatsspital Zurich, Zurich, Switzerland; 10Johannes Gutenberg Universitat, Mainz, Germany; 11Hopital Saint Joseph, Marseille Cedex, France; 12Centro Hospitalar de Lisboa Central, Lisbon, Portugal; 13Hospital Vall d'Hebron, Barcelona, Spain; 14Alfred Hospital, Melbourne, Victoria, Australia; 15Auckland Clinical Studies, Auckland, New Zealand; 16Clinical Research - Virology, Boehringer Ingelheim Pharm. Inc., Ridgefield, CT, USA; 17Department of Clinical Research, Boehringer Ingelheim GmbH, Biberach, Germany
|
| |
|
|
|
|
|
